Karachi: IBL healthcare limited informed Karachi Stock Exchange about the board meeting of the company scheduled to be held on September 29, 2015 at Karachi. The agenda of the meeting shall be consideration of annual accounts for the period ended June 30, 2015.
Further, the closed period of the company shall be from September 23, 2015 to September 29, 2015.
The company was incorporated in Pakistan as a private limited company on July 14, 1997. In November 2008 the Company was converted into a public limited company. The foundations of the company are laid under the Companies Ordinance, 1984. The company is a wholly owned subsidiary of Searle Pakistan Limited. The principal business activities of the company are marketing and selling, distribution of healthcare products. The shares of the company are quoted on the Karachi Stock Exchange. The registered office of the company is located in Karachi.
The portfolio of the company includes divided into three distinct categories, namely Nutritional Products, Plasma Protein Components and Hospital Disposables. The company is the major partner of globally recognized multinational organizations having expertise in their respective fields of health care products. The partners of the company include MeadJohnson Nutritionals – USA, Tyco Health Care – USA, Intersurgical – UK, Terumo – Japan and Molnlycke – Sweden.
The symbol “IBLHL” is being used by the stock exchanges for the shares of IBL Healthcare Limited.